Electroporation and Electrochemotherapy in Gynecological and Breast Cancer Treatment

Molecules. 2022 Apr 12;27(8):2476. doi: 10.3390/molecules27082476.

Abstract

Gynecological carcinomas affect an increasing number of women and are associated with poor prognosis. The gold standard treatment plan is mainly based on surgical resection and subsequent chemotherapy with cisplatin, 5-fluorouracil, anthracyclines, or taxanes. Unfortunately, this treatment is becoming less effective and is associated with many side effects that negatively affect patients' physical and mental well-being. Electroporation based on tumor exposure to electric pulses enables reduction in cytotoxic drugs dose while increasing their effectiveness. EP-based treatment methods have received more and more interest in recent years and are the subject of a large number of scientific studies. Some of them show promising therapeutic potential without using any cytotoxic drugs or molecules already present in the human body (e.g., calcium electroporation). This literature review aims to present the fundamental mechanisms responsible for the course of EP-based therapies and the current state of knowledge in the field of their application in the treatment of gynecological neoplasms.

Keywords: breast cancer; calcium electroporation; electrochemotherapy; electroporation; gynecological cancer.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Breast Neoplasms* / drug therapy
  • Breast Neoplasms* / etiology
  • Cisplatin / therapeutic use
  • Electrochemotherapy* / methods
  • Electroporation / methods
  • Female
  • Humans

Substances

  • Antineoplastic Agents
  • Cisplatin